It’s More Than a Career, It’s a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
As the Clinical Research Coordinator for Blood Cancer and Bone Marrow Transplant (BMT) research you are responsible for overall clinical operations of the facility’s blood cancer research program including enrollment, regulatory, quality, and site operations.
You will support enrolling patients onto clinical trials through recruitment, screening, enrollment, treatment, and follow-up of eligible participants according to protocol requirements.
You will review the study design and inclusion/exclusion criteria with physicians and patients
You will ensure the protection of study patients by verifying informed consent procedures and adhering to protocol requirements
You will collect, complete, and enter data into study specific case report forms (CRFs) or electronic data capture systems within study required timelines
You will ensure the integrity of the data submitted on case report forms or other data collection tools by careful source document review and monitoring data for missing or implausible data
You will create study specific tools for source documentation when not provided by sponsor
You will generate and track drug shipments, lab kits, and other supplies
You will be responsible foraccurate and complete documentation of protocol requirements according to site work instructions and standard operating procedures (SOPs)
You will track and report adverse events, serious adverse events, protocol waivers, and deviations
You will maintainaccurate and complete records, including regulatory documents, signed informed consent forms, source documentation, drug dispensing logs, screening and enrollment logs, and study communications
You will coordinate regular site research meetings
You will attend study-specific on-site meetings/visits, investigator meetings, conference calls, and other coordinator meetings, as required and you will work closely with monitors, study teams and site staff to ensure quality study data
You will communicate site status through a weekly activity report to appropriate site/management colleagues
An Associate’s Degree, preferably a Bachelor’s Degree
Knowledge of medical and research terminology
Knowledge of FDA Code of Federal Regulations and GCP
Knowledge of the clinical research processes
Public presentation skills
The ability to manage multiple ongoing priorities and projects with a diverse team of professionals
At least one year of oncology experience, preferably in hematology/oncology and/or transplant
At least one year of experience in a clinical research setting
At least one year of experience managing blood cancer and/or BMT clinical trials is preferred
Research certification (ACRP or CCRP) is preferred
RN or LPN is preferred
Interested candidates should submit their application through https://www.scri.com/careers/. Applications will be accepted through December 15, 2025. Please ensure all required materials are included as outlined in the posting.
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 750 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at more than 250 locations in 24 states across the U.S. Please click here to learn more about our research offerings.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here.
As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
